Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation |
|---|
| Name (Synonyms) | Correlation |
|---|
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There are 2 clinical trials
The oral manifestation of COVID 19 that could help in the diagnosis of patient
Description: The presence or absence or oral manifestation like ulcer burning sensation..will be measured by yes or no using a list of question
Measure: Oral manifestation Time: 1monthonline questionnaire will be distributed in different country to detect the oral change in patient diagnosed with COVID-19
Description: number of patient with oral ulcer
Measure: oral ulcer Time: through study completion, an average of 1 monthDescription: change in salivary flow
Measure: hyposalivation Time: through study completion, an average of 1 monthAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports